(NYSE: GMED) Globus Medical's forecast annual revenue growth rate of 22.07% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Globus Medical's revenue in 2024 is $1,568,476,000.On average, 8 Wall Street analysts forecast GMED's revenue for 2024 to be $333,696,057,380, with the lowest GMED revenue forecast at $330,227,410,605, and the highest GMED revenue forecast at $335,992,920,738. On average, 8 Wall Street analysts forecast GMED's revenue for 2025 to be $358,506,567,713, with the lowest GMED revenue forecast at $355,623,271,157, and the highest GMED revenue forecast at $366,168,645,044.
In 2026, GMED is forecast to generate $387,008,818,521 in revenue, with the lowest revenue forecast at $378,595,965,910 and the highest revenue forecast at $408,127,453,006.